These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32535015)

  • 61. Immune response against lumpy skin disease after simultaneous vaccination of cattle with sheep pox and goat pox and foot and mouth disease vaccines.
    Sareyyüpoğlu B; Uzar S; Saraç F; Enül H; Adıay C; Çokçalışkan C; Arslan A; Öztap G; Gülyaz V
    Vet Microbiol; 2023 Jun; 281():109726. PubMed ID: 37054661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential antibody responses to the major antigenic sites of FMD virus serotype O after primo-vaccination, multiply-vaccination and after natural exposure.
    Biswal JK; Subramaniam S; Ranjan R; VanderWaal K; Sanyal A; Pattnaik B; Singh RK
    Infect Genet Evol; 2020 Mar; 78():104105. PubMed ID: 31706082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2015 Feb; 33(6):805-11. PubMed ID: 25528523
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thermostable negative-marker foot-and-mouth disease virus serotype O induces protective immunity in guinea pigs.
    Ranjitha HB; Dhanesh VV; Hosamani M; Sreenivasa BP; Jabeen U; Biswal JK; Saravanan P; Sanyal A; Bhanuprakash V; Basagoudanavar SH
    Appl Microbiol Biotechnol; 2023 Feb; 107(4):1285-1297. PubMed ID: 36656322
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
    Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immune response in dairy cattle against combined foot and mouth disease and haemorrhagic septicemia vaccine under field conditions.
    Muenthaisong A; Rittipornlertrak A; Nambooppha B; Tankaew P; Varinrak T; Pumpuang M; Muangthai K; Atthikanyaphak K; Singhla T; Pringproa K; Punyapornwithaya V; Sawada T; Sthitmatee N
    BMC Vet Res; 2021 May; 17(1):186. PubMed ID: 33952269
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sequence Analysis of Egyptian Foot-and-Mouth Disease Virus Field and Vaccine Strains: Intertypic Recombination and Evidence for Accidental Release of Virulent Virus.
    Abd El Rahman S; Hoffmann B; Karam R; El-Beskawy M; Hamed MF; Forth LF; Höper D; Eschbaumer M
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899903
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emergence of a novel sublineage, MYMBD21 under SA-2018 lineage of Foot-and-Mouth Disease Virus serotype O in Bangladesh.
    Hossain KA; Anjume H; Alam KMM; Yeamin A; Akter S; Hossain MA; Sultana M
    Sci Rep; 2023 Jun; 13(1):9817. PubMed ID: 37330573
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
    Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
    Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mouse model as an efficacy test for foot-and-mouth disease vaccines.
    Gnazzo V; Quattrocchi V; Soria I; Pereyra E; Langellotti C; Pedemonte A; Lopez V; Marangunich L; Zamorano P
    Transbound Emerg Dis; 2020 Nov; 67(6):2507-2520. PubMed ID: 32320534
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection and Molecular Characterization of Foot and Mouth Disease Viruses from Outbreaks in Some States of Northern Nigeria 2013-2015.
    Ehizibolo DO; Haegeman A; De Vleeschauwer AR; Umoh JU; Kazeem HM; Okolocha EC; Van Borm S; De Clercq K
    Transbound Emerg Dis; 2017 Dec; 64(6):1979-1990. PubMed ID: 28097814
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Herd Immunity Against Foot-and-Mouth Disease Under Different Vaccination Practices in India.
    Sharma GK; Mahajan S; Matura R; Biswal JK; Ranjan R; Subramaniam S; Misri J; Bambal RG; Pattnaik B
    Transbound Emerg Dis; 2017 Aug; 64(4):1133-1147. PubMed ID: 26920973
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Humoral Immune Response in Calves Vaccinated with Monovalent Vaccines or a Trivalent Combination Thereof and Matching of These Vaccines to the Selected Circulating Foot-and-Mouth Disease Viruses in Ethiopia.
    Woldemariyam FT; Negessu D; Bilata T; Muluneh A; Gebreweld DS; Ebisa IT; Paeshuyse J
    Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631920
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emergence of antigenic variants of Foot-and-Mouth Disease Virus serotype O in Ecuador and preliminary evaluation of a field strain as a vaccine candidate.
    Maradei E; Malirat V; Beascoechea CP; Espinoza AM; Novo SG; Smitsaart E; Salgado G; Mattion N; Toledo JR; Bergmann IE
    Vaccine; 2014 May; 32(21):2446-51. PubMed ID: 24625343
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
    Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fasciola hepatica infection modifies IgG1 specific immune response to foot-and-mouth disease virus induced by vaccination.
    Costa M; Mansilla F; Manuel Sala J; Saravia A; Ubios D; Lores P; Capozzo AV; Freire T
    Vaccine; 2024 Jan; 42(3):541-547. PubMed ID: 38185546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.